Studies on the pharmacology of skeletal muscle in culture: site of action of nicotinic agonists

Alan L. Harvey, William F. Dryden

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The hypothesis that nicotinic agonists other than acetylcholine act by releasing endogenous acetylcholine was examined using nerve-free cultures of chick embryonic skeletal muscle. All nicotinic agonists tested (acetylcholine, carbachol, DMPP, tetramethylammonium and nicotine) depolarized the cultured skeletal muscle fibres. The depolarization was antagonised by triethylcholine, hemicholinium-3, tetraethylammonium and hexamethonium, substances that have been suggested to act by preventing agonists acting on nerve terminals. The results confirm that triethylcholine, hemicholinium-3, tetraethylammonium and hexamethonium have postjunctional blocking actions. We conclude that nicotinic agonists act directly on cholinoreceptors and do not require the presence of endogenous acetylcholine.

LanguageEnglish
Pages131-134
Number of pages4
JournalEuropean Journal of Pharmacology
Volume28
Issue number1
DOIs
Publication statusPublished - 1 Jan 1974

Fingerprint

Nicotinic Agonists
Acetylcholine
Skeletal Muscle
Hemicholinium 3
Pharmacology
Hexamethonium
Tetraethylammonium
Dimethylphenylpiperazinium Iodide
Skeletal Muscle Fibers
Carbachol
Nicotine
triethylcholine

Keywords

  • acetylcholine receptors
  • cultered skeletal muscle
  • ganglion-blocking drugs
  • hemicholinium-like drugs
  • site of action
  • 1,1 dimethyl 4 phenylpiperazinium
  • 1,1 dimethyl 4 phenylpiperazinium iodide
  • carbachol
  • cholinergic receptor
  • ganglion blocking agent
  • hemicholinium 3
  • hexamethonium
  • tetramethylammonium
  • drug antagonism
  • in vitro study
  • membrane depolarization
  • muscle fiber culture

Cite this

@article{e11260b3433446f285fee946d7e8d233,
title = "Studies on the pharmacology of skeletal muscle in culture: site of action of nicotinic agonists",
abstract = "The hypothesis that nicotinic agonists other than acetylcholine act by releasing endogenous acetylcholine was examined using nerve-free cultures of chick embryonic skeletal muscle. All nicotinic agonists tested (acetylcholine, carbachol, DMPP, tetramethylammonium and nicotine) depolarized the cultured skeletal muscle fibres. The depolarization was antagonised by triethylcholine, hemicholinium-3, tetraethylammonium and hexamethonium, substances that have been suggested to act by preventing agonists acting on nerve terminals. The results confirm that triethylcholine, hemicholinium-3, tetraethylammonium and hexamethonium have postjunctional blocking actions. We conclude that nicotinic agonists act directly on cholinoreceptors and do not require the presence of endogenous acetylcholine.",
keywords = "acetylcholine receptors, cultered skeletal muscle, ganglion-blocking drugs, hemicholinium-like drugs, site of action, 1,1 dimethyl 4 phenylpiperazinium, 1,1 dimethyl 4 phenylpiperazinium iodide, carbachol, cholinergic receptor, ganglion blocking agent, hemicholinium 3, hexamethonium, tetramethylammonium, drug antagonism, in vitro study, membrane depolarization, muscle fiber culture",
author = "Harvey, {Alan L.} and Dryden, {William F.}",
year = "1974",
month = "1",
day = "1",
doi = "10.1016/0014-2999(74)90123-X",
language = "English",
volume = "28",
pages = "131--134",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
number = "1",

}

Studies on the pharmacology of skeletal muscle in culture : site of action of nicotinic agonists. / Harvey, Alan L.; Dryden, William F.

In: European Journal of Pharmacology, Vol. 28, No. 1, 01.01.1974, p. 131-134.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Studies on the pharmacology of skeletal muscle in culture

T2 - European Journal of Pharmacology

AU - Harvey, Alan L.

AU - Dryden, William F.

PY - 1974/1/1

Y1 - 1974/1/1

N2 - The hypothesis that nicotinic agonists other than acetylcholine act by releasing endogenous acetylcholine was examined using nerve-free cultures of chick embryonic skeletal muscle. All nicotinic agonists tested (acetylcholine, carbachol, DMPP, tetramethylammonium and nicotine) depolarized the cultured skeletal muscle fibres. The depolarization was antagonised by triethylcholine, hemicholinium-3, tetraethylammonium and hexamethonium, substances that have been suggested to act by preventing agonists acting on nerve terminals. The results confirm that triethylcholine, hemicholinium-3, tetraethylammonium and hexamethonium have postjunctional blocking actions. We conclude that nicotinic agonists act directly on cholinoreceptors and do not require the presence of endogenous acetylcholine.

AB - The hypothesis that nicotinic agonists other than acetylcholine act by releasing endogenous acetylcholine was examined using nerve-free cultures of chick embryonic skeletal muscle. All nicotinic agonists tested (acetylcholine, carbachol, DMPP, tetramethylammonium and nicotine) depolarized the cultured skeletal muscle fibres. The depolarization was antagonised by triethylcholine, hemicholinium-3, tetraethylammonium and hexamethonium, substances that have been suggested to act by preventing agonists acting on nerve terminals. The results confirm that triethylcholine, hemicholinium-3, tetraethylammonium and hexamethonium have postjunctional blocking actions. We conclude that nicotinic agonists act directly on cholinoreceptors and do not require the presence of endogenous acetylcholine.

KW - acetylcholine receptors

KW - cultered skeletal muscle

KW - ganglion-blocking drugs

KW - hemicholinium-like drugs

KW - site of action

KW - 1,1 dimethyl 4 phenylpiperazinium

KW - 1,1 dimethyl 4 phenylpiperazinium iodide

KW - carbachol

KW - cholinergic receptor

KW - ganglion blocking agent

KW - hemicholinium 3

KW - hexamethonium

KW - tetramethylammonium

KW - drug antagonism

KW - in vitro study

KW - membrane depolarization

KW - muscle fiber culture

UR - http://www.scopus.com/inward/record.url?scp=0016251904&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(74)90123-X

DO - 10.1016/0014-2999(74)90123-X

M3 - Article

VL - 28

SP - 131

EP - 134

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -